ARK Invest's position in TEVJF, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| IZRL | 45,253 | $2.0M | 1.65% | #18 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-12 | IZRL | Sell | Trimmed | 2,603 | $114K |
| 2026-10-15 | IZRL | Sell | Trimmed | 19,148 | $787K |
| 2026-09-11 | IZRL | Buy | New position | 68,295 | $2.5M |
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and…
See TEVJF's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open TEVJF on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.